Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: The development of a prediction model

George Dranitsaris; Daniel Rayson; Mark Vincent; Jose Chang; Karen Gelmon; David Sandor; Greg Reardon

doi:10.1097/COC.0b013e318165c01d

Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: The development of a prediction model

George Dranitsaris, Daniel Rayson, Mark Vincent, Jose Chang, Karen Gelmon, David Sandor, Greg Reardon

科研成果: 期刊稿件 › 文章 › 同行评审

源语言	英语
页（从-至）	369-374
页数	6
期刊	American Journal of Clinical Oncology: Cancer Clinical Trials
卷	31
期	4
DOI	https://doi.org/10.1097/COC.0b013e318165c01d
出版状态	已出版 - 8月 2008
已对外发布	是

!!!ASJC Scopus Subject Areas

肿瘤学
癌症研究

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1097/COC.0b013e318165c01d

其它文件与链接

引用此

Dranitsaris, G., Rayson, D., Vincent, M., Chang, J., Gelmon, K., Sandor, D., & Reardon, G. (2008). Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: The development of a prediction model. American Journal of Clinical Oncology: Cancer Clinical Trials, 31(4), 369-374. https://doi.org/10.1097/COC.0b013e318165c01d

Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: The development of a prediction model. / Dranitsaris, George; Rayson, Daniel; Vincent, Mark 等.
在: American Journal of Clinical Oncology: Cancer Clinical Trials, 卷 31, 号码 4, 08.2008, 页码 369-374.

科研成果: 期刊稿件 › 文章 › 同行评审

Dranitsaris, G, Rayson, D, Vincent, M, Chang, J, Gelmon, K, Sandor, D & Reardon, G 2008, 'Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: The development of a prediction model', American Journal of Clinical Oncology: Cancer Clinical Trials, 卷 31, 号码 4, 页码 369-374. https://doi.org/10.1097/COC.0b013e318165c01d

Dranitsaris G, Rayson D, Vincent M, Chang J, Gelmon K, Sandor D 等. Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: The development of a prediction model. American Journal of Clinical Oncology: Cancer Clinical Trials. 2008 8月;31(4):369-374. doi: 10.1097/COC.0b013e318165c01d

Dranitsaris, George ; Rayson, Daniel ; Vincent, Mark 等. / Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin : The development of a prediction model. 在: American Journal of Clinical Oncology: Cancer Clinical Trials. 2008 ; 卷 31, 号码 4. 页码 369-374.

@article{da78e52f007544a5ba471c4294b30e38,

title = "Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: The development of a prediction model",

keywords = "Anthracyclines, Breast Cancer, Doxorubicin, Neutropenia, Prediction, Risk",

author = "George Dranitsaris and Daniel Rayson and Mark Vincent and Jose Chang and Karen Gelmon and David Sandor and Greg Reardon",

year = "2008",

month = aug,

doi = "10.1097/COC.0b013e318165c01d",

language = "English",

volume = "31",

pages = "369--374",

journal = "American Journal of Clinical Oncology: Cancer Clinical Trials",

issn = "0277-3732",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin

T2 - The development of a prediction model

AU - Dranitsaris, George

AU - Rayson, Daniel

AU - Vincent, Mark

AU - Chang, Jose

AU - Gelmon, Karen

AU - Sandor, David

AU - Reardon, Greg

PY - 2008/8

Y1 - 2008/8

KW - Anthracyclines

KW - Breast Cancer

KW - Doxorubicin

KW - Neutropenia

KW - Prediction

KW - Risk

UR - http://www.scopus.com/inward/record.url?scp=55449115686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55449115686&partnerID=8YFLogxK

U2 - 10.1097/COC.0b013e318165c01d

DO - 10.1097/COC.0b013e318165c01d

M3 - Article

C2 - 18845996

AN - SCOPUS:55449115686

SN - 0277-3732

VL - 31

SP - 369

EP - 374

JO - American Journal of Clinical Oncology: Cancer Clinical Trials

JF - American Journal of Clinical Oncology: Cancer Clinical Trials

IS - 4

ER -

Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: The development of a prediction model

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此